U.S. Compounding Pharmacies Market Size By Pharmacy Type (503A, 503B), By Sterility (Sterile, Non-sterile), By Product (Oral [Solid preparations, Liquid preparations], Topical [Ointments, Creams, Gels, Pastes], Rectal [Suppositories, Enema], Parenteral [LVP, SVP], Nasal, Ophthalmic, Otic), By Application (Paediatric, Adult, Geriatric, Veterinary), By Compounding Type (Pharmaceutical Ingredient Alteration [PIA], Currently Unavailable Pharmaceutical Manufacturing [CUPM], Pharmaceutical Dosage Alteration [PDA]), By Therapeutic Area (Hormone Replacement, Pain Management, Dermatology, Specialty Drugs, Nutritional Supplements) Industry Analysis Report, Application Potential, Competitive Market Share & Forecast, 2020 – 2026

Published Date: Mar 2020  |  Report ID: GMI2961  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 95   |   Base Year: 2019




Summary Table of Contents Industry Coverage Methodology

Report Content

Chapter 1.  Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data sources

1.4.1.  Secondary

1.4.1.1.  Paid sources

1.4.1.2.  Unpaid sources

1.4.2.  Primary

Chapter 2.  Executive Summary

2.1. U.S. compounding pharmacies industry 3600 synopsis, 2015 - 2026

Chapter 3.  U.S. Compounding Pharmacies Industry Insights

3.1. Industry segmentation

3.2. Industry size and forecast, 2015 - 2026

3.3. Industry impact forces

3.3.1.  Growth drivers

3.3.1.1. Increasing geriatric population and improved longevity

3.3.1.2. Growing acceptance of personalized medicines

3.3.1.3. Increasing drug shortage in the country

3.3.1.4.    Convenience of using compounded drugs

3.3.1.5. Growing demand for compounded bioidentical menopausal hormone therapy (BMHT) among women

3.3.2.  Industry pitfalls & challenges

3.3.2.1. Changing regulatory specifications

3.3.2.2.    Issues related to safety standards of compounded drugs

3.4. Growth potential analysis

3.4.1.  By pharmacy type

3.4.2.  By sterility

3.4.3.  By product

3.4.4.  By application

3.4.5.  By compounding type

3.4.6.  By therapeutic area

3.5. Regulatory landscape

3.6. Reimbursement landscape

3.7. Innovative compounding technologies

3.7.1.  Web-based quality management system

3.7.2.  Digital tools

3.8. Porter’s analysis

3.9. Competitive landscape, 2019

3.9.1.   Strategy dashboard

3.10.  PESTEL analysis

Chapter 4.  U.S. Compounding Pharmacies Market, By Pharmacy Type

4.1. U.S. compounding pharmacies market share, by pharmacy type, 2019 & 2026

4.2. 503A compounding pharmacy

4.2.1.  U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

4.3. 503B compounding pharmacy

4.3.1.  U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

Chapter 5.  U.S. Compounding Pharmacies Market, By Sterility

5.1. U.S. compounding pharmacies market share, by sterility, 2019 & 2026

5.2. Sterile

5.2.1.  U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

5.3. Non-sterile

5.3.1.  U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

Chapter 6.  U.S. Compounding Pharmacies Market, By Product

6.1. U.S. compounding pharmacies market share, by product, 2019 & 2026

6.2. Oral

6.2.1.  U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.2.2.  Solid preparations

6.2.2.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.2.2.2.  Tablets

6.2.2.2.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.2.2.3.  Capsules

6.2.2.3.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.2.2.4.  Granules

6.2.2.4.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.2.2.5.  Powder

6.2.2.5.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.2.2.6.  Others

6.2.2.6.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.2.3.  Liquid preparations

6.2.3.1.  U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.2.3.2.  Solutions

6.2.3.2.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.2.3.3.  Suspension

6.2.3.3.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.2.3.4.  Emulsion

6.2.3.4.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.2.3.5.  Syrup

6.2.3.5.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.2.3.6.  Others

6.2.3.6.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.3. Topical

6.3.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.3.2.  Ointments

6.3.2.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.3.3.  Creams

6.3.3.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.3.4.  Gels

6.3.4.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.3.5.  Pastes

6.3.5.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.3.6.  Others

6.3.6.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.4. Rectal

6.4.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.4.2.  Suppositories

6.4.2.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.4.3.  Enema

6.4.3.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.4.4.  Others

6.4.4.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.5. Parenteral

6.5.1.  U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.5.2.  Large Volume Parenteral (LVP)

6.5.2.1.  U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.5.3.  Small Volume Parenteral (SVP)

6.5.3.1.  U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.6. Nasal

6.6.1.  U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.7. Ophthalmic

6.7.1.  U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

6.8. Otic

6.8.1.  U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

Chapter 7.  U.S. Compounding Pharmacies Market, By Application

7.1. U.S. compounding pharmacies market share, by application, 2019 & 2026

7.2. Pediatric

7.2.1.  U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

7.3. Adult

7.3.1.  U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

7.4. Geriatric

7.4.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

7.5. Veterinary

7.5.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

Chapter 8.     U.S. Compounding Pharmacies Market, By Compounding Type

8.1. U.S. compounding pharmacies market share, by compounding type, 2019 & 2026

8.2. Pharmaceutical Ingredient Alteration (PIA)

8.2.1.  U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

8.3. Currently Unavailable Pharmaceutical Manufacturing (CUPM)

8.3.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

8.4. Pharmaceutical Dosage Alteration (PDA)

8.4.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

8.5. Others

8.5.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

Chapter 9.  U.S. Compounding Pharmacies Market, By Therapeutic Area

9.1. U.S. compounding pharmacies market share, by therapeutic area, 2019 & 2026

9.2. Hormone Replacement

9.2.1.  U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

9.3. Pain Management

9.3.1.  U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

9.4. Dermatology

9.4.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

9.5. Specialty Drugs

9.5.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

9.6. Nutritional Supplements

9.6.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

9.7. Others

9.7.1. U.S. compounding pharmacies market size, 2015 - 2026 (USD Mn)

Chapter 10.  Company Profiles

10.1.  B. Braun Medical

10.1.1.   Business overview

10.1.2.   Financial data

10.1.3.   Product landscape

10.1.4.   Strategic outlook

10.1.5.   SWOT analysis

10.2.  US Compounding Pharmacy

10.2.1.   Business overview

10.2.2.   Financial data

10.2.3.   Product landscape

10.2.4.   Strategic outlook

10.2.5.   SWOT analysis

10.3.  Fagron

10.3.1.   Business overview

10.3.2.   Financial data

10.3.3.   Product landscape

10.3.4.   Strategic outlook

10.3.5.   SWOT analysis

10.4.  Dougherty's Pharmacy, Inc

10.4.1. Business overview

10.4.2.   Financial data

10.4.3.   Product landscape

10.4.4.   Strategic outlook

10.4.5.   SWOT analysis

10.5.   Fresenius Kabi AG (Fresenius SE & Co. KGaA)

10.5.1.   Business overview

10.5.2.   Financial data

10.5.3.   Product landscape

10.5.4.   Strategic outlook

10.5.5.   SWOT analysis

10.6.   Institutional Pharmacy Solutions

10.6.1.   Business overview

10.6.2.   Financial data

10.6.3.   Product landscape

10.6.4.   Strategic outlook

10.6.5.   SWOT analysis

10.7.   ImprimisRx (Harrow Health, Inc.)

10.7.1.   Business overview

10.7.2.   Financial data

10.7.3.   Product landscape

10.7.4.   Strategic outlook

10.7.5.   SWOT analysis

10.8.   McGuff Company Inc. (McGuff Compounding Pharmacy Services)

10.8.1.   Business overview

10.8.2.   Financial data

10.8.3.   Product landscape

10.8.4.   Strategic outlook

10.8.5.   SWOT analysis

10.9.   PharMEDium Healthcare Holdings

10.9.1.   Business overview

10.9.2.   Financial data

10.9.3.   Product landscape

10.9.4.   Strategic outlook

10.9.5.   SWOT analysis

10.10. Pencol Compounding Pharmacy

10.10.1. Business overview

10.10.2. Financial data

10.10.3. Product landscape

10.10.4. Strategic outlook

10.10.5. SWOT analysis

10.11. Rx3 Compounding Pharmacy

10.11.1. Business overview

10.11.2. Financial data

10.11.3. Product landscape

10.11.4. Strategic outlook

10.11.5. SWOT analysis

10.12. Triangle Compounding Pharmacies (Panaceutics)

10.12.1. Business overview

10.12.2. Financial data

10.12.3. Product landscape

10.12.4. Strategic outlook

10.12.5. SWOT analysis

10.13. Wedgewood Village Pharmacy, Inc.

10.13.1. Business overview

10.13.2. Financial data

10.13.3. Product landscape

10.13.4. Strategic outlook

10.13.5. SWOT analysis
 

Data Tables

TABLE 1.    U.S. compounding pharmacies industry 360° synopsis, 2015 - 2026

TABLE 2.    U.S. compounding pharmacies market, 2015 - 2026 (USD Million)

TABLE 3.    Industry impact forces

TABLE 4.    U.S. compounding pharmacies market, by pharmacy type, 2015 - 2026 (USD Million)

TABLE 5.    U.S. compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)

TABLE 6.    U.S. compounding pharmacies market, by product, 2015 - 2026 (USD Million)

TABLE 7.    U.S. compounding pharmacies oral market, 2015 - 2026 (USD Million)

TABLE 8.    U.S. compounding pharmacies solid preparations market, 2015- 2026, (USD Mn)

TABLE 9.    U.S. compounding pharmacies liquid preparations market, 2015 - 2026, (USD Million)

TABLE 10.   U.S. compounding pharmacies topical market, 2015 - 2026, (USD Million)

TABLE 11.   U.S. compounding pharmacies rectal market, 2015 - 2026 (USD Million)

TABLE 12.   U.S. compounding pharmacies market, by application, 2015 - 2026 (USD Million)

TABLE 13.   U.S. compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)

TABLE 14.   U.S. compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)

 

Charts & Figures

FIG. 1    Industry segmentation

FIG. 2    U.S. compounding pharmacies market, 2015 - 2026 (USD Million)

FIG. 3    Growth potential analysis, by pharmacy type

FIG. 4    Growth potential analysis, by sterility

FIG. 5    Growth potential analysis, by product

FIG. 6    Growth potential analysis, by application

FIG. 7    Growth potential analysis, by compounding type

FIG. 8    Growth potential analysis, by therapeutic area

FIG. 9    Porter’s Analysis

FIG. 10    Strategic Dashboard

FIG. 11  PESTEL Analysis

Buy NowImmediate delivery available

Single User: $2,850 Access to only 1 person; cannot be shared; cannot be printed
Multi User: $4,850 Access for 2 to 5 users only within same department of one company
Enterprise User: $6,850 Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

GMIPulse Subscription Trial

Take a free trial of GMIPuse, our report store; designed to provide clients a range of market research services, all on a single platform.

Start Your Free Trial

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X